| Basic documents: (including amendments adopted up to 31 May 2019) World Health Organization World Health Organization, 2020 | 917 | 2020 |
| Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP) HQ McLean, AP Fiebelkorn, JL Temte, GS Wallace, ... MMWR Recomm Rep 62 (RR-04), 1-34, 2013 | 800 | 2013 |
| Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies EA Belongia, MD Simpson, JP King, ME Sundaram, NS Kelley, ... The Lancet Infectious Diseases 16 (8), 942-951, 2016 | 697 | 2016 |
| Decline in mortality due to varicella after implementation of varicella vaccination in the United States HQ Nguyen, AO Jumaan, JF Seward New England Journal of Medicine 352 (5), 450-458, 2005 | 533 | 2005 |
| Influenza vaccine effectiveness in the United States during 2012–2013: variable protection by age and virus type HQ McLean, MG Thompson, ME Sundaram, BA Kieke, M Gaglani, ... The Journal of infectious diseases 211 (10), 1529-1540, 2015 | 321 | 2015 |
| Influenza vaccine effectiveness in the United States during the 2015–2016 season ML Jackson, JR Chung, LA Jackson, CH Phillips, J Benoit, AS Monto, ... New England Journal of Medicine 377 (6), 534-543, 2017 | 316 | 2017 |
| Transmission of SARS-COV-2 infections in households—Tennessee and Wisconsin, April–September 2020 CG Grijalva MMWR. Morbidity and Mortality Weekly Report 69, 2020 | 299 | 2020 |
| Impact of repeated vaccination on vaccine effectiveness against influenza A (H3N2) and B during 8 seasons HQ McLean, MG Thompson, ME Sundaram, JK Meece, DL McClure, ... Clinical infectious diseases 59 (10), 1375-1385, 2014 | 295 | 2014 |
| 2014–2015 influenza vaccine effectiveness in the United States by vaccine type RK Zimmerman, MP Nowalk, J Chung, ML Jackson, LA Jackson, ... Clinical Infectious Diseases, ciw635, 2016 | 288 | 2016 |
| Repeated annual influenza vaccination and vaccine effectiveness: review of evidence EA Belongia, DM Skowronski, HQ McLean, C Chambers, ME Sundaram, ... Expert review of vaccines 16 (7), 723-736, 2017 | 286 | 2017 |
| Early estimates of seasonal influenza vaccine effectiveness-United States, January 2015 B Flannery, J Clippard, RK Zimmerman, MP Nowalk, ML Jackson, ... MMWR Morb Mortal Wkly Rep 64 (1), 10-5, 2015 | 256 | 2015 |
| Interim estimates of 2017–18 seasonal influenza vaccine effectiveness—United States, February 2018 B Flannery MMWR. Morbidity and mortality weekly report 67, 2018 | 217 | 2018 |
| Influenza vaccine effectiveness against 2009 pandemic influenza A (H1N1) virus differed by vaccine type during 2013–2014 in the United States M Gaglani, J Pruszynski, K Murthy, L Clipper, A Robertson, M Reis, ... The Journal of infectious diseases 213 (10), 1546-1556, 2016 | 197 | 2016 |
| Outpatient antibiotic prescribing for acute respiratory infections during influenza seasons FP Havers, LA Hicks, JR Chung, M Gaglani, K Murthy, RK Zimmerman, ... JAMA network open 1 (2), e180243-e180243, 2018 | 195 | 2018 |
| Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience MJ Papania, GS Wallace, PA Rota, JP Icenogle, AP Fiebelkorn, ... JAMA pediatrics 168 (2), 148-155, 2014 | 189 | 2014 |
| Spread of antigenically drifted influenza A (H3N2) viruses and vaccine effectiveness in the United States during the 2018–2019 season B Flannery, RJG Kondor, JR Chung, M Gaglani, M Reis, RK Zimmerman, ... The Journal of infectious diseases 221 (1), 8-15, 2020 | 188 | 2020 |
| Male circumcision in Siaya and Bondo Districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision KE Agot, JN Kiarie, HQ Nguyen, JO Odhiambo, TM Onyango, NS Weiss JAIDS Journal of Acquired Immune Deficiency Syndromes 44 (1), 66-70, 2007 | 166 | 2007 |
| Interim estimates of 2019–20 seasonal influenza vaccine effectiveness—United States, February 2020 FS Dawood MMWR. Morbidity and mortality weekly report 69, 2020 | 153 | 2020 |
| The immunological basis for immunization series: module 3: tetanus World Health Organization World Health Organization, 2018 | 152* | 2018 |
| Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response HQ Nguyen, AS Magaret, MM Kitahata, SE Van Rompaey, A Wald, ... Aids 22 (8), 937-945, 2008 | 147 | 2008 |
